Medical Transcription Billing Stock Price, News & Analysis (NASDAQ:MTBC)

Medical Transcription Billing trades on the NASDAQ under the ticker symbol "MTBC."

Medical Transcription Billing Corp (NASDAQ:MTBC) posted its quarterly earnings data on Wednesday, August, 7th. The technology company reported ($0.19) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.19). The technology company earned $16.75 million during the quarter, compared to the consensus estimate of $15.33 million. Medical Transcription Billing had a negative net margin of 9.21% and a negative return on equity of 17.50%. View Medical Transcription Billing's Earnings History.

Medical Transcription Billing is scheduled to release their next quarterly earnings announcement on Wednesday, November 6th 2019. View Earnings Estimates for Medical Transcription Billing.

Medical Transcription Billing will be holding an earnings conference call on Wednesday, November 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Medical Transcription Billing updated its FY 2019 earnings guidance on Tuesday, October, 15th. The company provided EPS guidance of for the period. The company issued revenue guidance of $62.677 million, compared to the consensus revenue estimate of $64.4 million.

3 Wall Street analysts have issued 1-year price targets for Medical Transcription Billing's shares. Their predictions range from $6.00 to $6.00. On average, they anticipate Medical Transcription Billing's share price to reach $6.00 in the next year. This suggests a possible upside of 53.8% from the stock's current price. View Analyst Price Targets for Medical Transcription Billing.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medical Transcription Billing in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medical Transcription Billing.

Media coverage about MTBC stock has been trending negative recently, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Medical Transcription Billing earned a coverage optimism score of -2.0 on InfoTrie's scale. They also assigned news articles about the technology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Medical Transcription Billing.

Medical Transcription Billing saw a decline in short interest in September. As of September 30th, there was short interest totalling 109,200 shares, a decline of 36.6% from the August 30th total of 172,300 shares. Based on an average daily volume of 28,700 shares, the days-to-cover ratio is presently 3.8 days. Approximately 1.8% of the shares of the company are sold short. View Medical Transcription Billing's Current Options Chain.

Some companies that are related to Medical Transcription Billing include Inspired Entertainment (INSE), Iclick Interactive Asia Group (ICLK), Xunlei (XNET), Red Violet (RDVT), MAM Software Group (MAMS), SharpSpring (SHSP), Great Elm Capital Group (GEC), Cyren (CYRN), CLPS (CLPS), Gridsum (GSUM), NetSol Technologies (NTWK), Aware (AWRE), Destiny Media Technologies (DSNY), FalconStor Software (FALCD) and Mobivity (MFON).

Based on aggregate information from My MarketBeat watchlists, some companies that other Medical Transcription Billing investors own include BlackBerry (BB), NVIDIA (NVDA), Sophiris Bio (SPHS), Verastem (VSTM), Microbot Medical (MBOT), Micron Technology (MU), Alibaba Group (BABA), Advanced Micro Devices (AMD), Etsy (ETSY) and Interpace Diagnostics Group (IDXG).

Shares of MTBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MTBC stock can currently be purchased for approximately $3.90.

Medical Transcription Billing has a market capitalization of $46.93 million and generates $50.55 million in revenue each year. The technology company earns $-2,140,000.00 in net income (profit) each year or ($0.59) on an earnings per share basis. Medical Transcription Billing employs 2,400 workers across the globe.View Additional Information About Medical Transcription Billing.

The official website for Medical Transcription Billing is http://www.mtbc.com/.

Medical Transcription Billing's mailing address is 7 CLYDE ROAD, SOMERSET NJ, 08873. The technology company can be reached via phone at 732-873-5133.